No Result
View All Result
  • Login
Saturday, March 21, 2026
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Business

These Dividend Aristocrats Wildly Outperformed the S&P 500

by FeeOnlyNews.com
2 months ago
in Business
Reading Time: 5 mins read
A A
0
These Dividend Aristocrats Wildly Outperformed the S&P 500
Share on FacebookShare on TwitterShare on LInkedIn


Dividend stocks are my go-to choice for chasing stability, not market-beating returns. These stocks often reward patience, not speed, and with that, they tend to lag the S&P 500. However, sometimes, a few happen to break the mold.

Sure, there are many stocks that perform more or less as well as the broad market, but can they do that while maintaining a long record of consistent dividend growth? That’s rare, and it’s what makes certain names stand out. Not because they are flashy, but because they pair performance with consistent income.

That’s where the Dividend Aristocrats come in. These are S&P 500 listed companies that have increased their dividends for at least 25 consecutive years. And just in time for the weekend, I wanted to see which of them are not only delivering reliable income, but also beating the S&P 500’s 52-week 13.59% return.

Using Barchart’s Stock Screener, I selected the following filters to get my list:

52-Week Performance Difference From Market: I am looking for companies that have outperformed the S&P 500 by any value.

52-Week Percent Change: Left blank so I can sort it from highest to lowest.

Current Analyst Rating: 3.5 – 5. Stocks rated  “Moderate” to “Strong Buy.”

Number of Analysts: 12 or more. More analysts suggest a stronger consensus on the rating.

I hit the screen and got 15 results. I will cover the three with the highest 52-week percent change.

Let’s kick off this list with the first Dividend Aristocrat:

Albemarle Corp is a chemical company and the world’s largest producer of lithium, a crucial component in batteries, including those for electric vehicles. It leverages advanced tools, such as nuclear magnetic resonance, which gives it a competitive advantage.

In its recent quarterly financials, sales were reported down 4% YOY to $1.3 billion, while its net loss improved 85% to almost $161 million. Regardless, Albemarle pays a forward annual dividend of $1.62, translating to a yield of around 0.9%.

While yield alone might not be a big deal, the stock gained 108.66% over the past 52 weeks, easily outperforming the S&P 500’s 13.59% gain over the same period. Not only that, a consensus among 26 analysts rates the stock a “Moderate Buy” with as much as 12% upside potential should it reach its $210 high target.

The second Dividend Aristocrat on my list is C.H. Robinson Ww, one of the largest global logistics companies, which includes third-party logistics. C.H. Robinson is one of the earliest adopters of AI, with its Lean AI  initiative already delivering measurable productivity gains, faster pricing, and sustained market outperformance.

In its most recent financials, the company’s sales decreased 11% YOY to $4.1 billion, while net income rose 68% to $163 million. C.H. Robinson Ww pays a forward annual dividend of $2.52, translating to a yield of approximately 1.4%.

Like the previous Dividend Aristocrat, the yield isn’t anything to write home about. But CHRW stock rose 69.03% over the past 52 weeks, also outperforming the S&P 500. Finally, a consensus among 26 analysts rates the stock a “Moderate Buy” with a high target price of $210- suggesting as much as 18% upside over the next year.

The third and final Dividend Aristocrat on my list is Cardinal Health, a globally recognized company that manufactures and distributes pharmaceutical and medical products, expanding through initiatives like ContinuCare Pathway, which scales direct-to-patient delivery nationwide.

In its most recent quarterly financials, Cardinal reported that sales rose 22% YOY to $64 billion, while net income grew 8% from the same period last year to $450 million. Cardinal Health also pays a forward annual dividend of $2.04, translating to a yield of around 1%.

Meanwhile, the stock gained 60.69% over the past 52 weeks, again, easily outperforming the S&P 500 by a huge margin. Plus, a consensus among 16 analysts rates the stock a “Strong Buy”, making it the highest-rated stock in this list, with the rating increasing over the last three months. That said, based on target prices alone, there’s as much as 21% upside- should the stock hit its high target of $250.

So, there you have it, three Dividend Aristocrats that are (easily) beating the S&P 500. If we believe the high target prices, these stocks could grow 19-20% in 2026. Still, the upside is just a bonus when it comes to dividend-investing. The real security comes from consistent payouts every time, during any market, and regardless of news- exactly what these companies have been doing. While these stocks may look very attractive today, always do your due diligence before investing.

On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com



Source link

Tags: AristocratsdividendOutperformedwildly
ShareTweetShare
Previous Post

Chase Sapphire Cardholders Get a Shot at World Cup Tickets

Next Post

Dow ends lower after topsy-turvy week, as Intel’s outlook weighs on market sentiment

Related Posts

Key deals this week: Ecolab, Novartis, 3M and more (MMM:NYSE)

Key deals this week: Ecolab, Novartis, 3M and more (MMM:NYSE)

by FeeOnlyNews.com
March 21, 2026
0

Mar 21, 2026, 3:15 PM ET3M Company (MMM) Stock, KKR Stock, ECL Stock, BDNCE Stock, SPGI:CA Stock, PSA Stock, NSA...

OpenAI cofounder says he hasn’t written a line of code in months and is in a ‘state of psychosis’

OpenAI cofounder says he hasn’t written a line of code in months and is in a ‘state of psychosis’

by FeeOnlyNews.com
March 21, 2026
0

Andrej Karpathy, an OpenAI cofounder and former director of AI at Tesla, admitted that he’s not on the forefront of the field...

DA Davidson Reaffirms Buy Rating for Commvault (CVLT)

DA Davidson Reaffirms Buy Rating for Commvault (CVLT)

by FeeOnlyNews.com
March 21, 2026
0

Commvault Systems Inc. (NASDAQ:CVLT) is one of the 11 best software application stocks to buy now. On March 17, Rudy...

Iran launches missiles at U.K.-U.S. base 2,500 away in the Indian Ocean

Iran launches missiles at U.K.-U.S. base 2,500 away in the Indian Ocean

by FeeOnlyNews.com
March 21, 2026
0

Israel’s defense minister threatened a surge in attacks against Iran on Saturday and Britain condemned Iran for targeting a joint...

T-Mobile, Verizon, AT&T Go All-In On Discounts As Churn Surge Hits

T-Mobile, Verizon, AT&T Go All-In On Discounts As Churn Surge Hits

by FeeOnlyNews.com
March 21, 2026
0

Promotional activity among the "Big 3" U.S. carriers—AT&T Inc., Verizon Communications Inc. and T-Mobile US, Inc.—is gaining momentum heading into...

Costco’s .50 hot dog will never change, CEO Ron Vachris promises

Costco’s $1.50 hot dog will never change, CEO Ron Vachris promises

by FeeOnlyNews.com
March 21, 2026
0

There’s no better way to fuel up for traipsing the Costco aisles for hours than a $1.50 hot dog and...

Next Post
Dow ends lower after topsy-turvy week, as Intel’s outlook weighs on market sentiment

Dow ends lower after topsy-turvy week, as Intel's outlook weighs on market sentiment

Democrats File Amendments to Crypto Market Structure Bill

Democrats File Amendments to Crypto Market Structure Bill

  • Trending
  • Comments
  • Latest
York IE Appoints Chuck Saia to its Strategic Advisory Board

York IE Appoints Chuck Saia to its Strategic Advisory Board

February 18, 2026
Judge orders SEC to release data behind B in WhatsApp fines

Judge orders SEC to release data behind $2B in WhatsApp fines

March 10, 2026
8 Cost-Cutting Moves Retirees Are Sharing Online in February

8 Cost-Cutting Moves Retirees Are Sharing Online in February

February 14, 2026
3 Grocery Chains That Give Seniors a “Gas Bonus” for Every  Spent

3 Grocery Chains That Give Seniors a “Gas Bonus” for Every $50 Spent

March 15, 2026
8 Procedures That Can Be Cheaper Without Insurance

8 Procedures That Can Be Cheaper Without Insurance

February 14, 2026
FPA partners with Snappy Kraken to update PlannerSearch

FPA partners with Snappy Kraken to update PlannerSearch

February 25, 2026
Dimona Hit Or Not? | Armstrong Economics

Dimona Hit Or Not? | Armstrong Economics

0
It’s Not Just What You Own, It’s How Much: Machine Learning and the Portfolio Construction Imperative

It’s Not Just What You Own, It’s How Much: Machine Learning and the Portfolio Construction Imperative

0
Key deals this week: Ecolab, Novartis, 3M and more (MMM:NYSE)

Key deals this week: Ecolab, Novartis, 3M and more (MMM:NYSE)

0
Ripple Study Reveals How Financial World Leaders Are Looking At The Market

Ripple Study Reveals How Financial World Leaders Are Looking At The Market

0
Crypto, tokenization and ETFs: SEC’s Peirce indicates openness

Crypto, tokenization and ETFs: SEC’s Peirce indicates openness

0
The ‘Medicare Advantage’ Switch: Why You Only Have Until March 31 to Return to Original Medicare

The ‘Medicare Advantage’ Switch: Why You Only Have Until March 31 to Return to Original Medicare

0
Key deals this week: Ecolab, Novartis, 3M and more (MMM:NYSE)

Key deals this week: Ecolab, Novartis, 3M and more (MMM:NYSE)

March 21, 2026
The ‘Medicare Advantage’ Switch: Why You Only Have Until March 31 to Return to Original Medicare

The ‘Medicare Advantage’ Switch: Why You Only Have Until March 31 to Return to Original Medicare

March 21, 2026
Ripple Study Reveals How Financial World Leaders Are Looking At The Market

Ripple Study Reveals How Financial World Leaders Are Looking At The Market

March 21, 2026
OpenAI cofounder says he hasn’t written a line of code in months and is in a ‘state of psychosis’

OpenAI cofounder says he hasn’t written a line of code in months and is in a ‘state of psychosis’

March 21, 2026
Dimona Hit Or Not? | Armstrong Economics

Dimona Hit Or Not? | Armstrong Economics

March 21, 2026
DA Davidson Reaffirms Buy Rating for Commvault (CVLT)

DA Davidson Reaffirms Buy Rating for Commvault (CVLT)

March 21, 2026
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Key deals this week: Ecolab, Novartis, 3M and more (MMM:NYSE)
  • The ‘Medicare Advantage’ Switch: Why You Only Have Until March 31 to Return to Original Medicare
  • Ripple Study Reveals How Financial World Leaders Are Looking At The Market
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.